Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Endo Pharma 1Q Net Drops 34% On Acquisition Costs
Endo Pharma 1Q Net Drops 34% On Acquisition Costs
Endo Pharma 1Q Net Drops 34% On Acquisition Costs
Submitted by
admin
on April 29, 2009 - 8:43am
Source:
WSJ Online
News Tags:
Endo
earnings
Headline:
Endo Pharma 1Q Net Drops 34% On Acquisition Costs
Do Not Allow Advertisers to Use My Personal information
